110 results
8-K
EX-99.2
WVE
Wave Life Sciences Ltd.
6 Mar 24
Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
7:39am
Healthy individual Huntington’s disease Stresses wtHTT Stresses wtHTT + ~50% decrease in wtHTT Healthy CNS function Synaptic dysfunction | Cell death
8-K
EX-99.1
WVE
Wave Life Sciences Ltd.
8 Jan 24
Regulation FD Disclosure
8:11am
in the US and more Loss of wtHTT functions than 200,000 at risk of developing HD Synaptic dysfunction | Healthy CNS function Cell death
8-K
EX-99.1
WVE
Wave Life Sciences Ltd.
15 Dec 23
Regulation FD Disclosure
8:36am
to HD Stresses wtHTT Stresses wtHTT mHTT + ~50% decrease in wtHTT Healthy CNS function Synaptic dysfunction | Cell death | Neurodegeneration Loss
424B5
3fct 9dws47
8 Dec 23
Prospectus supplement for primary offering
6:06am
424B5
ys5 tceuenzw96
6 Dec 23
Prospectus supplement for primary offering
4:13pm
8-K
EX-99.1
llf 1chl007s3
9 Nov 23
Regulation FD Disclosure
4:27pm
8-K
EX-99.1
hmrkbgb 19
2 Oct 23
Regulation FD Disclosure
7:31am
8-K
EX-99.1
2jgyt2ua16cjwg0kjt3d
5 Sep 23
Regulation FD Disclosure
4:05pm
8-K
EX-10.2
i5u 1ty7x
7 Aug 23
Departure of Directors or Certain Officers
5:01pm
8-K
EX-10.1
w10ks1nh8on2nw5rz
7 Aug 23
Departure of Directors or Certain Officers
5:01pm
8-K
EX-99.2
2qpjss0br
3 Aug 23
Wave Life Sciences Reports Second Quarter 2023 Financial Results and Provides Business Update
7:37am
8-K
EX-99.2
txviuas7
23 May 23
Wave Life Sciences Announces Topline Results from Phase 1b/2a FOCUS-C9 Study of WVE-004 for C9orf72-associated
7:48am
8-K
EX-99.2
3mvuexyifaxx0gyb
3 May 23
Wave Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update
7:43am
8-K
EX-99.1
krrkfx5h
15 Nov 22
Regulation FD Disclosure
8:31am
8-K
EX-99.1
n2jneu5
4 Oct 22
Regulation FD Disclosure
7:35am
8-K
EX-99.1
675pzu tbwibdjkkz
17 Aug 22
Regulation FD Disclosure
4:31pm